Why Lineage Cell Therapeutics, Inc. (LCTX) stock is Popping High Today?
Lineage Cell Therapeutics, Inc. (LCTX) stock reported additional cases of retinal tissue restoration in its Phase 1/2a study of lead product candidate OpRegen after which the LCTX stock happened to be green after declining in the previous trading session and LCTX stock price saw a push of 10.55% to reach $2.62 a share at the […]
Lineage Cell Therapeutics Inc. (LCTX) stock shows an incline. Why?
Lineage Cell Therapeutics, Inc. (LCTX), a clinical-stage biotechnology company specializing to develop allogeneic cell therapies for degenerative retinal diseases, neurological conditions associated with demyelination, and assisting the body in detecting and fighting cancer, reported financial and operating report for the first quarter of 2021. At last check in premarket trading, the share price of Lineage […]
